Download PDF
Aktuelle Neurologie 2006; 33(6): 349-367
DOI: 10.1055/s-2005-915446
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Neurosarkoidose

NeurosarcoidosisE.  Jacobasch1 , H.  Reichmann1
  • 1Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Klinik und Poliklinik für Neurologie
Further Information

Publication History

Publication Date:
02 August 2006 (online)

Also available at
    Permissions and Reprints

Weiterbildungsziele In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden: Überblick über den aktuellen Stand der Ätiopathogenese der Sarkoidose Epidemiologie der Neurosarkoidose mögliche klinische Manifestationen und typische Konstellationen der Neurosarkoidose mögliche und notwendige Diagnostik der Neurosarkoidose Therapie der Neurosarkoidose

Literatur

  • 1 Zajicek J P. Neurosarcoidosis.  Curr Opin Neurol. 2000;  13 323-325
    CrossrefPubMedGoogle Scholar
  • 2 Baughman R P, Lower E E, Bois R M du. Sarcoidosis.  Lancet. 2003;  361 1111-1118
    CrossrefPubMedGoogle Scholar
  • 3 Stern B J. Neurological complications of sarcoidosis.  Curr Opin Neurol. 2004;  17 311-316
    CrossrefPubMedGoogle Scholar
  • 4 Hoitsma E, Faber C G, Drent M, Sharma O P. Neurosarcoidosis: a clinical dilemma.  Lancet Neurol. 2004;  3 397-407
    CrossrefPubMedGoogle Scholar
  • 5 Gullapalli D, Phillips 2nd  L H. Neurosarcoidosis.  Curr Neurol Neurosci Rep. 2004;  4 441-447
    PubMedGoogle Scholar
  • 6 Crystal R G. Sarcoidosis. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds) Harrison's Principles of Internal Medicine, 14th ed. New York; McGraw-Hill 1998: 1922-1928
    Google Scholar
  • 7 Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurological sarcoidosis.  Arch Intern Med. 1997;  157 1864-1868
    CrossrefPubMedGoogle Scholar
  • 8 Sharma O P. Neurosarcoidosis. A personal perspective based on the study of 37 patients.  Chest. 1997;  112 220-228
    CrossrefPubMedGoogle Scholar
  • 9 Vinas F C, Rengachary S. Diagnosis and management of neurosarcoidosis.  J Clin Neurosci. 2001;  8 505-513
    CrossrefPubMedGoogle Scholar
  • 10 Zajicek J P, Scolding N J, Foster O. et al . Central nervous system sarcoidosis - diagnosis and management.  Q J Med. 1999;  92 103-117
    CrossrefPubMedGoogle Scholar
  • 11 Iwai K, Tachibana T, Takemura T. et al . Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan.  Acta Pathol Jpn. 1993;  43 372-376
    PubMedGoogle Scholar
  • 12 Leiba H, Siatkowski R M, Culbertson W W, Glaser J S. Neurosarcoidosis presenting as an intracranial mass in childhood.  J Neuroophthalmol. 1996;  16 269-273
    PubMedGoogle Scholar
  • 13 Ng K L, McDermott N, Romanowski C A, Jackson A. Neurosarcoidosis masquerading as glioma of the optic chiasm in a child.  Postgrad Med J. 1995;  71 265-268
    PubMedGoogle Scholar
  • 14 Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features.  Sarcoidosis. 1989;  6 138-146
    PubMedGoogle Scholar
  • 15 Hunninghake G W, Costabel U, Ando M. et al . ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.  Sarcoidosis Vasc Diffuse Lung Dis. 1999;  16 149-173
    PubMedGoogle Scholar
  • 16 Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore.  Curr Opin Pulm Med. 2002;  8 424-428
    CrossrefPubMedGoogle Scholar
  • 17 Damian M S, Reichmann H. Neurosarkoidose. In: Hopf C, Deuschl G, Diener HC, Reichmann H (Hrsg) Neurologie in Praxis und Klinik. 3., vollständig überarbeitete Auflage. Band I. Stuttgart, New York; Georg Thieme Verlag 1999: 881-886
    Google Scholar
  • 18 Radziwill A, Weder B. Neurosarkoidose des zentralen Nervensystems. Analyse des Langzeitverlaufes in 8 Fällen.  Nervenarzt. 1995;  66 915-922
    PubMedGoogle Scholar
  • 19 Achiron L, Strominger M, Witkin N, Primo S. Sarcoid optic neuropathy: a case report.  J Am Optom Assoc. 1995;  66 646-651
    PubMedGoogle Scholar
  • 20 Krejchi D, Caldemeyer K S, Vakili S T, Pritz M B. Neurosarcoidosis resembling meningioma: MRI characteristics and pathologic correlation.  J Neuroimaging. 1998;  8 177-179
    PubMedGoogle Scholar
  • 21 O'Reilly B J, Burrows E H. VIIIth cranial nerve involvement in sarcoidosis.  J Laryngol Otol. 1995;  109 1089-1093
    PubMedGoogle Scholar
  • 22 Sugaya F, Shijubo N, Takahashi H, Abe S. Sudden hearing loss as the initial manifestation of neurosarcoidosis.  Sarcoidosis Vasc Diffus Lung Dis. 1996;  13 54-56
    PubMedGoogle Scholar
  • 23 Oki M, Takizawa S, Ohnuki Y, Shinohara Y. MRI findings of VIIth cranial nerve involvement in sarcoidosis.  Br J Radiol. 1997;  70 859-861
    PubMedGoogle Scholar
  • 24 Gizzi M S, Lidov M, Rosenbaum D. Neurosarcoidosis presenting as a tumour of the basal ganglia and brainstem: sequential MRI.  Neurol Res. 1993;  15 93-96
    PubMedGoogle Scholar
  • 25 Oksanen V. Neurosarcoidosis.  Sarcoidosis. 1994;  11 76-79
    PubMedGoogle Scholar
  • 26 Bona J R, Fackler S M, Fendley M J, Nemeroff C B. Neurosarcoidosis as a cause of refractory psychosis: a complicated case report.  Am J Psychiatry. 1998;  155 1106-1108
    PubMedGoogle Scholar
  • 27 Stubgen J P. Neurosarcoidosis presenting as a retroclival mass.  Surg Neurol. 1995;  43 85-87
    CrossrefPubMedGoogle Scholar
  • 28 Maisel J A, Lynam T. Unexpected death in a young pregnant woman: unusual presentation of neurosarcoidosis.  ANN Emerg Med. 1996;  28 94-97
    PubMedGoogle Scholar
  • 29 Sato N, Sze G, Kim J H. Cystic pituary mass in neurosarcoidosis.  Am J Neuroradiol. 1997;  18 1182-1185
    PubMedGoogle Scholar
  • 30 Guoth M S, Kim J, Lotbiniere A C de, Brines M L. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass.  Am J Med Sci. 1998;  315 220-224
    CrossrefPubMedGoogle Scholar
  • 31 Chapelon C, Ziza J M, Piette J C. et al . Neurosarcoidosis: signs, course and treatment in 35 confirmed cases.  Medicine. 1990;  69 261-276
    PubMedGoogle Scholar
  • 32 Fried E D, Landau A J, Sher J H, Rao C. Spinal cord sarcoidosis: a case report and review of the literature.  J Assoc Acad Minor Phys. 1993;  4 132-137
    PubMedGoogle Scholar
  • 33 Ku A, Lachmann E, Tunkel R, Nagler W. Neurosarcoidosis of the conus medullaris and cauda equina presenting as paraparesis: case report and review of the literature.  Paraplegia. 1996;  34 116-120
    PubMedGoogle Scholar
  • 34 Abbrey L E, Rosenblum M K, Angelis L M de. Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy.  J Neurooncol. 1998;  39 261-265
    CrossrefPubMedGoogle Scholar
  • 35 Stjernberg N, Cajander S, Truedsson H, Uddenfeldt P. Muscle involvement in sarcoidosis.  Acta Med Scand. 1981;  209 213-216
    PubMedGoogle Scholar
  • 36 Dale J C, O'Brien J F. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis (letter).  Mayo Clin Proc. 1999;  74 535
    PubMedGoogle Scholar
  • 37 Tahmoush A J, Amir M S, Connor W W. et al . CSF-ACE activity in probable CNS neurosarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 191-197
    PubMedGoogle Scholar
  • 38 Scott T F. Neurosarcoidosis: progress and clinical aspects.  Neurology. 1993;  43 1-8
    PubMedGoogle Scholar
  • 39 Worofka B, Lassmann J, Bauer K, Kristoferitsch W. Praktische Liquorzelldiagnostik 1. Auflage. Wien, New York; Springer-Verlag 1997
    Google Scholar
  • 40 Lexa F J, Grossman R I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.  Am J Neuroradiology. 1994;  15 973-982
    PubMedGoogle Scholar
  • 41 Sharma O P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.  Arch Neurol. 1998;  55 1248-1254
    CrossrefPubMedGoogle Scholar
  • 42 Sherman J L, Stern B J. Sarcoidosis of the CNS: Comparison of unenhanced and enhanced MR images.  Am J Neuroradiology. 1990;  11 915-923
    PubMedGoogle Scholar
  • 43 Salvage D R, Spencer J A, Batchelor A G. et al . Sarcoid involvement of the supraorbital nerve: MR and histologic findings.  Am J Neuroradiol. 1997;  18 1785-1787
    PubMedGoogle Scholar
  • 44 Sugita M, Sano M, Uchigata M. et al . Facial nerve enhancement on gadolinium-DTPA in a case with neurosarcoidosis.  Intern Med. 1997;  36 825-828
    PubMedGoogle Scholar
  • 45 Leu N H, Chen C Y, Wu C S. et al . Primary chiasmal sarcoid granuloma: MRI.  Neuroradiology. 1999;  41 440-442
    CrossrefPubMedGoogle Scholar
  • 46 Duffey P, Bates D. Transient focal neurological deficit in sarcoidosis.  Sarcoidosis Vasc Diffus Lung Dis. 1997;  14 171-172
    PubMedGoogle Scholar
  • 47 Osborn A G, Tong K A. Handbook of Neuroradiology: Brain and Skull. Second edition. St. Louis; Mosby 1996
    Google Scholar
  • 48 Maña J. Magnetic resonance imaging and nuclear imaging in sarcoidosis.  Curr Opin Pulm Med. 2002;  8 457-463
    CrossrefPubMedGoogle Scholar
  • 49 Jackson R J, Goodman J C, Huston D P, Harper R L. Parafalcine and bilateral convexity neurosarcoidosis mimicking meningeoma: case report and review of the literature.  Neurosurgery. 1998;  42 635-638
    PubMedGoogle Scholar
  • 50 Agbogu B N, Stern B J, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis.  Arch Neurol. 1995;  52 875-879
    CrossrefPubMedGoogle Scholar
  • 51 Stern B J, Schonfeld S A, Sewell C. et al . The treatment of neurosarcoidosis with cyclosporine.  Arch Neurol. 1992;  49 1065-1072
    PubMedGoogle Scholar
  • 52 Haraoui B. Differentiating the efficacy of the tumor necrosis factor inhibitors.  Semin Arthritis Rheum. 2005;  34 (5, Suppl 1) 7-11
    CrossrefPubMedGoogle Scholar
  • 53 Pettersen J A, Zochodne D W, Bell R B. et al . Refractory neurosarcoidosis responding to infliximab.  Neurology. 2002;  59 1660-1661
    CrossrefPubMedGoogle Scholar
  • 54 Morcos Z. Refractory neurosarcoidosis responding to infliximab.  Neurology. 2003;  60 1220-1221
    PubMedGoogle Scholar
  • 55 Carter J D, Valeriano J, Vasey F B, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab.  Am J Med. 2004;  117 277-279
    CrossrefPubMedGoogle Scholar
  • 56 Sollberger M, Fluri F, Baumann T. et al . Successful treatment of steroid-refractory neurosarcoidosis with infliximab.  J Neurol. 2004;  251 760-761
    PubMedGoogle Scholar
  • 57 Doty J D, Mazur J E, Judson M A. Treatment of sarcoidosis with infliximab.  Chest. 2005;  127 1064-1071
    CrossrefPubMedGoogle Scholar
  • 58 Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis.  Am J Respir Crit Care Med. 1997;  155 1665-1669
    CrossrefPubMedGoogle Scholar
  • 59 Walter M C, Lochmuller H, Schlotter-Weigel B. et al . Successful treatment of muscle sarcoidosis with thalidomide.  Acta Myol. 2003;  22 22-25
    PubMedGoogle Scholar
  • 60 Utz J P, Limper A H, Kalra S. et al . Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis.  Chest. 2003;  124 177-185
    CrossrefPubMedGoogle Scholar
  • 61 Callejas-Rubio J L, Ortego-Centeno N, Lopez-Perez L, Benticuaga M N. Treatment of therapy-resistant sarcoidosis with adalimumab.  Clin Rheumatol. 2005;  1 - 2 , [Epub ahead of print]
    PubMedGoogle Scholar
  • 62 Kouba D J, Mimouni D, Rencic A, Nousari H C. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.  Br J Dermatol. 2003;  148 147-148
    CrossrefPubMedGoogle Scholar
  • 63 Tikoo R K, Kupersmith M J, Finlay J L. Treatment of refractory neurosarcoidosis with cladribine.  N Engl J Med. 2004;  350 1798-1799
    PubMedGoogle Scholar

Dr. med. E. Jacobasch

Universitätsklinikum Carl Gustav Carus · Klinik und Poliklinik für Neurologie

Fetscherstraße 74

01307 Dresden

Email: eleonore.jacobasch@neuro.med.tu-dresden.de

      >